{"disease":{"id":"breast-lesions-of-uncertain-malignant-potential","name":"breast lesions of uncertain malignant potential"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07428733","title":"Gene Methylation for Diagnosis of Breast Lesions","phase":"NA","overall_status":"COMPLETED","enrollment_count":401,"lead_sponsor_name":"Institute of Oncology Ljubljana","has_results":false},{"nct_id":"NCT07416500","title":"BRCA1, RASSF1A and PTEN Methylation in Breast Lesions of Uncertain Malignant Potential","phase":"NA","overall_status":"COMPLETED","enrollment_count":301,"lead_sponsor_name":"Institute of Oncology Ljubljana","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}